Literature DB >> 33317895

Factors Associated With Postpartum Diabetes Screening in Women With Gestational Diabetes and Medicaid During Pregnancy.

Cynthia J Herrick1, Matthew R Keller2, Anne M Trolard3, Ben P Cooper4, Margaret A Olsen2, Graham A Colditz5.   

Abstract

INTRODUCTION: Women with gestational diabetes are 7 times more likely to develop type 2 diabetes and require lifelong diabetes screening. Loss of health coverage after pregnancy, as occurs in states that did not expand Medicaid, limits access to guideline-driven follow-up care and fosters health inequity. This study aims to understand the factors associated with the receipt of postpartum diabetes screening for women with gestational diabetes in a state without Medicaid expansion.
METHODS: Electronic health record and Medicaid claims data were linked to generate a retrospective cohort of 1,078 women with gestational diabetes receiving care in Federally Qualified Health Centers in Missouri from 2010 to 2015. In 2019-2020, data were analyzed to determine the factors associated with the receipt of recommended postpartum diabetes screening (fasting plasma glucose, 2-hour oral glucose tolerance test, or HbA1c in specified timeframes) using a Cox proportional hazards model through 18 months of follow-up.
RESULTS: Median age in this predominantly urban population was 28 (IQR=24-33) years. Self-reported racial or ethnic minorities comprised more than half of the population. Only 9.7% of women were screened at 12 weeks, and 20.8% were screened at 18 months. Prenatal certified diabetes education (adjusted hazard ratio=1.74, 95% CI=1.22, 2.49) and access to public transportation (adjusted hazard ratio=1.70, 95% CI=1.13, 2.54) were associated with increased screening in a model adjusted for race/ethnicity, the total number of prenatal visits, the use of diabetes medication during pregnancy, and a pregnancy-specific comorbidity index that incorporated age.
CONCLUSIONS: This study underscores the importance of access to public transportation, prenatal diabetes education, and continued healthcare coverage for women on Medicaid to support the receipt of guideline-recommended follow-up care and improve health equity.
Copyright © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33317895      PMCID: PMC7851940          DOI: 10.1016/j.amepre.2020.08.028

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  29 in total

1.  Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy.

Authors:  Susan E Andrade; Tiffany A Moore Simas; Denise Boudreau; Marsha A Raebel; Sengwee Toh; Beth Syat; Inna Dashevsky; Richard Platt
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-08-22       Impact factor: 2.890

2.  Racial and ethnic disparities in diabetes risk after gestational diabetes mellitus.

Authors:  A H Xiang; B H Li; M H Black; D A Sacks; T A Buchanan; S J Jacobsen; J M Lawrence
Journal:  Diabetologia       Date:  2011-10-21       Impact factor: 10.122

3.  ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus.

Authors: 
Journal:  Obstet Gynecol       Date:  2018-02       Impact factor: 7.661

4.  Validity of using ICD-9-CM codes to identify selected categories of obstetric complications, procedures and co-morbidities.

Authors:  Sarah L Goff; Penelope S Pekow; Glenn Markenson; Alexander Knee; Lisa Chasan-Taber; Peter K Lindenauer
Journal:  Paediatr Perinat Epidemiol       Date:  2012-07-23       Impact factor: 3.980

Review 5.  Gestational diabetes and the incidence of type 2 diabetes: a systematic review.

Authors:  Catherine Kim; Katherine M Newton; Robert H Knopp
Journal:  Diabetes Care       Date:  2002-10       Impact factor: 19.112

6.  Validation of administrative data case definitions for gestational diabetes mellitus.

Authors:  S L Bowker; A Savu; N K Lam; J A Johnson; P Kaul
Journal:  Diabet Med       Date:  2015-12-24       Impact factor: 4.359

7.  Prenatal counseling on type 2 diabetes risk, exercise, and nutrition affects the likelihood of postpartum diabetes screening after gestational diabetes.

Authors:  Kai E Jones; Yan Yan; Graham A Colditz; Cynthia J Herrick
Journal:  J Perinatol       Date:  2018-01-03       Impact factor: 2.521

8.  Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus.

Authors:  Jean M Lawrence; Mary Helen Black; Jin-Wen Hsu; Wansu Chen; David A Sacks
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152

9.  The Effect of Clinical Chorioamnionitis on Cesarean Delivery in the United States.

Authors:  Kerry M Bommarito; Gilad A Gross; Denise M Willers; Victoria J Fraser; Margaret A Olsen
Journal:  Health Serv Res       Date:  2016-02-03       Impact factor: 3.402

10.  Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study.

Authors:  Assiamira Ferrara; Tiffany Peng; Catherine Kim
Journal:  Diabetes Care       Date:  2008-11-04       Impact factor: 17.152

View more
  3 in total

1.  Understanding Gestational Diabetes, Future Diabetes Risk, and Diabetes Prevention: A Qualitative Study of Patient, Provider, and Staff Perspectives.

Authors:  Hannah R Lucas; Roxann C Williams; Laura N Hollar; Bethany Johnson-Javois; Heidi B Miller; Amanda Stoermer; Graham A Colditz; Aimee S James; Cynthia J Herrick
Journal:  Clin Diabetes       Date:  2022-01

2.  Clinical Care Among Individuals with Prediabetes in Primary Care: a Retrospective Cohort Study.

Authors:  Eva Tseng; Nowella Durkin; Jeanne M Clark; Nisa M Maruthur; Jill A Marsteller; Jodi B Segal
Journal:  J Gen Intern Med       Date:  2022-03-02       Impact factor: 6.473

3.  Uptake of guideline-recommended postpartum diabetes screening among diverse women with gestational diabetes: associations with patient factors in an integrated health system in USA.

Authors:  Susan D Brown; Monique M Hedderson; Yeyi Zhu; Ai-Lin Tsai; Juanran Feng; Charles P Quesenberry; Assiamira Ferrara
Journal:  BMJ Open Diabetes Res Care       Date:  2022-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.